Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.34 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | SRC | P12931 | 1/20 | 0.33 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.33 |
| ▸ | GSK3A | P49840 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29393804 | 1.00 | MEN1 (0.37) | MEN1KMT2AMAPK8MAPK10MAPT | |
| SCHEMBL29660819 | 0.90 | HCRTR1 (0.41) | MEN1KMT2AMAPK8MAPK10MAPT | |
| SCHEMBL18291946 | 0.90 | HCRTR1 (0.41) | MEN1KMT2AMAPK8MAPK10MAPT | |
| SCHEMBL29013586 | 0.90 | HCRTR1 (0.41) | MEN1KMT2AMAPK8MAPK10MAPT | |
| SCHEMBL2853900 | 0.90 | SRC (0.36) | MEN1KMT2AMAPK8MAPK10MAPT | |
| SCHEMBL2108015 | 0.90 | SRC (0.36) | MEN1KMT2AMAPK8MAPK10MAPT | |
| SCHEMBL2108009 | 0.90 | SRC (0.36) | MEN1KMT2AMAPK8MAPK10MAPT | |
| SCHEMBL24023024 | 0.89 | MAPK8 (0.36) | MEN1KMT2AMAPK8MAPK10MAPT | |
| SCHEMBL24023065 | 0.85 | MAPK8 (0.34) | MEN1KMT2AMAPK8MAPK10SMN1; SMN2 | |
| SCHEMBL20823283 | 0.84 | SMN1; SMN2 (0.39) | MEN1KMT2ANPSR1ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250241304-A1 | FUNGICIDAL COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2025-07-31 | — | — | US | disclosed |
| CN-111194314-B | Microbicidal pyridine amide derivative | 先正达参股股份有限公司 | 2022-12-30 | — | — | CN | disclosed |
| US-11185074-B2 | Microbiocidal quinoline (thio)carboxamide derivatives | SYNGENTA PARTICIPATIONS AG (CH) | 2021-11-30 | — | — | US | disclosed |
| EP-2670239-B1 | FORMULATION FOR THE ANTIMICROBIAL AND FUNGICIDAL TREATMENT OF POLYMERIC MATERIALS, IN PARTICULAR OF PAINTS AND COATINGS | SANITIZED AG (CH) | 2015-08-12 | — | — | EP | disclosed |
| US-20150144027-A1 | PARTICULATE WOOD PRESERVATIVE AND METHOD FOR PRODUCING THE SAME | KOPPERS INC. (F/K/A KOPPERS INDUSTRIES, INC.) | 2015-05-28 | — | — | US | disclosed |
| US-8871277-B2 | Particulate wood preservative and method for producing the same | OSMOSE, INC. (US) | 2014-10-28 | — | — | US | disclosed |
| WO-2014102228-A1 | FORMULATION FOR THE ANTIMICROBIAL TREATMENT OF POLYMER COMPOSITIONS | SANITIZED AG (CH) | 2014-07-03 | — | — | WO | disclosed |
| EP-2749167-A1 | Formulation for the antimicrobial treatment of polyvinyl chloride compositions | Sanitized AG (CH) | 2014-07-02 | — | — | EP | disclosed |
| US-20130324457-A1 | 1-ARYL-5-ALKYL PYRAZOLE DERIVATIVE COMPOUNDS, PROCESSES OF MAKING AND METHODS OF USING THEREOF | AVENTIS AGRICULTURE (FR) | 2013-12-05 | — | — | US | disclosed |
| US-20130230575-A1 | PARTICULATE WOOD PRESERVATIVE AND METHOD FOR PRODUCING THE SAME | OSMOSE, INC. (US) | 2013-09-05 | — | — | US | disclosed |
| WO-1996032235-A1 | TIMBER PRESERVATIVE CONTAINING A COPPER COMPOUND | BAYER AKTIENGESELLSCHAFT (DE) | 1996-10-17 | — | — | WO | disclosed |
| WO-1996029314-A1 | THIOCARBAMOYL COMPOUNDS | BAYER AKTIENGESELLSCHAFT (DE) | 1996-09-26 | — | — | WO | disclosed |
| EP-0730517-A1 | TIMBER PRESERVATIVE CONTAINING A COPPER COMPOUND | BAYER AG (DE) | 1996-09-11 | — | — | EP | disclosed |
| WO-1996025044-A1 | S-ARYL CYANIMIDOTHIO COMPOUNDS FOR MATERIAL PROTECTION | BAYER AKTIENGESELLSCHAFT (DE) | 1996-08-22 | — | — | WO | disclosed |
| EP-0726710-A1 | STABILISATION OF IODINE COMPOUNDS USING INORGANIC SUPPORTING MATERIALS FOR USE IN MATERIAL PROTECTION | BAYER AG (DE) | 1996-08-21 | — | — | EP | disclosed |
| WO-1996010915-A1 | INSECTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1996-04-18 | — | — | WO | disclosed |
| EP-0705160-A1 | FUNGICIDAL ACTIVE-SUBSTANCE COMBINATION | BAYER AG (DE) | 1996-04-10 | — | — | EP | disclosed |
| WO-1995014558-A1 | TIMBER PRESERVATIVE CONTAINING A COPPER COMPOUND | BAYER AKTIENGESELLSCHAFT (DE) | 1995-06-01 | — | — | WO | disclosed |
| WO-1995012315-A1 | STABILISATION OF IODINE COMPOUNDS USING INORGANIC SUPPORTING MATERIALS FOR USE IN MATERIAL PROTECTION | BAYER AKTIENGESELLSCHAFT (DE) | 1995-05-11 | — | — | WO | disclosed |
| WO-1995000303-A1 | FUNGICIDAL ACTIVE-SUBSTANCE COMBINATION | BAYER AKTIENGESELLSCHAFT (DE) | 1995-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11185074-B2 | Microbiocidal quinoline (thio)carboxamide derivatives | IFNG, TLR1, IDO1 | MEN1 2747/4885KMT2A 1539/4885MAPK8 4031/4885 |
| US-20250241304-A1 | FUNGICIDAL COMPOUNDS | CYP1B1, CYP51A1, CYP1A1 | MEN1 420/4885KMT2A 2548/4885MAPK8 4077/4885 |
| US-20130324457-A1 | 1-ARYL-5-ALKYL PYRAZOLE DERIVATIVE COMPOUNDS, PROCESSES OF MAKING AND METHODS OF USING THEREOF | CBR3, CBR1, NR5A2 | MEN1 3084/4885KMT2A 3142/4885MAPK8 675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.